Both in Biotechnology
Compass Therapeutics vs Sutro Biopharma
Over the past year CMPX returned −79.9% and STRO returned −2.5%; their daily moves had a correlation of 0.10.
CMPX −79.9% STRO −2.5%Growth of $1, one year, split-adjusted
| Metric | CMPX | STRO |
|---|---|---|
| Price | $0.7720 | $9.60 |
| Market cap | $139.0M | $159.2M |
| Today | +2.52% | +0.95% |
| 1 month | −22.7% | −33.6% |
| 6 months | −58.7% | −74.5% |
| Year to date | −85.6% | −17.0% |
| 1 year | −79.4% | −12.7% |
| Revenue growth (YoY) | — | −84.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −391.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.5× |
| Net cash | $179.9M | $164.3M |
| Dividend yield | — | — |
| Volatility (60d) | 100.7% | 74.5% |
| Short % of float | 33.9% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).